PoNS Device

Helius Medical Technologies said it has a booth at a meeting for multiple sclerosis (MS) professionals to showcase its PoNS device and the progress made over the last year in providing access to the neuromodulation device, which is designed to improve walking ability in people with MS.

Helius Medical Technologies is collaborating with Lovell Government Services to make its PoNS device — designed to improve walking ability in people with multiple sclerosis (MS) — available to U.S. veterans and MS patients in other federal healthcare systems. The PoNS device, officially named the Portable Neuromodulation Stimulator, is…

Helius Medical Technologies will be showcasing its now-accredited PoNS device — designed to improve walking ability in people with multiple sclerosis (MS) — at this year’s American Physical Therapy Association (APTA) Combined Sections Meeting (CMS), slated for Feb. 15-17. The annual meeting, which will feature educational sessions, exhibits,…

The PoNS device — officially the Portable Neuromodulation Stimulator, designed to help improve walking ability in people with multiple sclerosis (MS) — has been granted the accreditation needed for Medicare and Medicaid coverage in the U.S., according to Helius Medical Technologies, which makes the device. That designation, called…

An agreement with Helius Medical Technologies has made HealthTech Connex (HTC) the exclusive provider, for at least the next five years, of the noninvasive Portable Neuromodulation Stimulator (PoNS) device in the Vancouver area of British Columbia in Canada. The new deal supplants an earlier clinical research and promotions…

Helius Medical Technologies will showcase its noninvasive Portable Neuromodulation Stimulator (PoNS) device and provide training to physical therapists who are interested in using the device for the treatment of multiple sclerosis (MS). The company will explain the benefits of PoNS…

People with multiple sclerosis (MS) in the U.S. now may order a Portable Neuromodulation Stimulator (PoNS) device online through a new e-commerce site launched by the device’s developer, Helius Medical Technologies. The website, built in partnership with the telehealth company UpScript, marks the first time…

For National Physical Therapy Month, Helius Medical Technologies is spotlighting physical therapists who make possible the success of the company’s portable neuromodulation stimulator (PONS) device to treat gait problems in people with multiple sclerosis (MS). Helius will broaden access to its free online PoNS training program by enabling…

Helius Medical Technologies has launched an online training module for physical therapists who wish to use the company’s Portable Neuromodulation Stimulator (PoNS) device to treat gait deficits in people with multiple sclerosis (MS). The on-demand training modules for healthcare providers in the U.S. are now live, with…

Using the portable neuromodulation stimulator (PoNS) device during a targeted exercise program significantly improves walking skills in people with multiple sclerosis (MS), according to recent real-word data. Notably, significant improvements were observed from the second week onward, and more than half of the 42 patients patients experienced clinically meaningful gains…

PoNS Device for MS-associated Gait Problems Now Available in US One clinical trial showed that MS patients who used the portable neuromodulation stimulator (PoNS) device as part of an exercise program had greater improvements in gait than those using only the exercise program. A second trial showed that those…

The portable neuromodulation stimulator (PoNS) device, which improves walking abilities in people with multiple sclerosis (MS), is now available commercially in the U.S. for patients ages 22 and older who have a prescription from their healthcare provider. The device was approved last year by the U.S. Food…

Helius Medical Technologies partnered with Breakthrough Health on a project focused on understanding how people with multiple sclerosis (MS) in the U.S. evaluate the therapies at their disposal in terms of how well they help their ability to walk. The collaboration will take advantage of an MS companion application, called…

Helius Medical Technologies has filed an application with the U.S. Food and Drug Administration (FDA) asking for de novo classification and clearance of its portable neuromodulation stimulator (PoNS) device for the treatment of walking deficits in multiple…

COVID-19 May Not Be Severe in MS Patients, Early Data from Italy Suggest Keep in mind that COVID-19 information is dynamic. New data about this illness appear every day. But all information I’ve seen so far agrees with this report, which indicates there’s no reason to think that living…

The neurotechnology company Helius Medical Technologies has received authorization from Health Canada to market its portable neuromodulation stimulator (PoNS) device to treat gait deficit in patients with mild-to-moderate multiple sclerosis…